Vidar Möller
Publikationer
2026
Clinical, epidemiological, and genomic perspectives on antibiotic resistance: From antibiotic usage to colonization, virulence, and infection with extended-spectrum β-lactamaseproducing Escherichia coli
(Doktorsavhandling, sammanläggning)
https://dx.doi.org/10.3384/9789181185294
2025
Virulence factors and outcomes in bacteremia caused by extended-spectrum ß-lactamase-producing uropathogenic Escherichia coli ST131-H30Rx in a Swedish county
BMC Infectious Diseases, Vol. 25, Artikel 1103
(Artikel i tidskrift)
https://dx.doi.org/10.1186/s12879-025-11519-9
2022
Risk factors and outcome due to extended-spectrum beta-lactamase-producing uropathogenic Escherichia coli in community-onset bloodstream infections: A ten-year cohort study in Sweden
PLOS ONE, Vol. 17, Artikel e0277054
(Artikel i tidskrift)
https://dx.doi.org/10.1371/journal.pone.0277054
2021
Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010-2018
Infectious Diseases, Vol. 53, s. 607-618
(Artikel i tidskrift)
https://dx.doi.org/10.1080/23744235.2021.1910338
2020
Low incidence of antibiotic-resistant bacteria in south-east Sweden: An epidemiologic study on 9268 cases of bloodstream infection
PLOS ONE, Vol. 15, Artikel e0230501
(Artikel i tidskrift)
https://dx.doi.org/10.1371/journal.pone.0230501